Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 112

1.

Correction: Role of computed tomography angiography on the management of overt obscure gastrointestinal bleeding.

Tseng CM, Lin IC, Chang CY, Wang HP, Chen CC, Mo LR, Lin JT, Tai CM.

PLoS One. 2018 Feb 28;13(2):e0193793. doi: 10.1371/journal.pone.0193793. eCollection 2018.

2.

Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy.

Chien NH, Huang YT, Wu CY, Chang CY, Wu MS, Kao JH, Mo LR, Tai CM, Lin CW, Yang TH, Lin JT, Hsu YC.

BMC Gastroenterol. 2017 Dec 8;17(1):154. doi: 10.1186/s12876-017-0697-3.

3.

Role of computed tomography angiography on the management of overt obscure gastrointestinal bleeding.

Tseng CM, Lin IC, Chang CY, Wang HP, Chen CC, Mo LR, Lin JT, Tai CM.

PLoS One. 2017 Mar 1;12(3):e0172754. doi: 10.1371/journal.pone.0172754. eCollection 2017. Erratum in: PLoS One. 2018 Feb 28;13(2):e0193793.

4.

Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy.

Hsu YC, Mo LR, Chang CY, Wu MS, Yang TH, Kao JH, Chen CC, Tseng CH, Tai CM, Lin CW, Wu CY, Lin JT.

J Gastroenterol Hepatol. 2017 Aug;32(8):1512-1519. doi: 10.1111/jgh.13728.

PMID:
28122151
5.

Community-based exercise training for people with chronic respiratory and chronic cardiac disease: a mixed-methods evaluation.

McNamara RJ, McKeough ZJ, Mo LR, Dallimore JT, Dennis SM.

Int J Chron Obstruct Pulmon Dis. 2016 Nov 16;11:2839-2850. eCollection 2016.

6.

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

Su TH, Hu TH, Chen CY, Huang YH, Chuang WL, Lin CC, Wang CC, Su WW, Chen MY, Peng CY, Chien RN, Huang YW, Wang HY, Lin CL, Yang SS, Chen TM, Mo LR, Hsu SJ, Tseng KC, Hsieh TY, Suk FM, Hu CT, Bair MJ, Liang CC, Lei YC, Tseng TC, Chen CL, Kao JH; C-TEAM study group and the Taiwan Liver Diseases Consortium.

Liver Int. 2016 Dec;36(12):1755-1764. doi: 10.1111/liv.13253. Epub 2016 Oct 4.

PMID:
27634134
7.

Comparative effectiveness of nucleos(t)ide analogues in chronic hepatitis B patients undergoing cytotoxic chemotherapy.

Tseng CM, Chen TB, Hsu YC, Chang CY, Lin JT, Mo LR.

Asia Pac J Clin Oncol. 2016 Dec;12(4):421-429. doi: 10.1111/ajco.12520. Epub 2016 Jul 20.

PMID:
27435683
8.

A case series on the use of circumferential radiofrequency ablation for early esophageal squamous neoplasias in patients with esophageal varices.

Wang WL, Chang IW, Chen CC, Chang CY, Mo LR, Lin JT, Wang HP, Lee CT.

Gastrointest Endosc. 2017 Feb;85(2):322-329. doi: 10.1016/j.gie.2016.06.045. Epub 2016 Jun 27.

PMID:
27365263
9.

Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy.

Liang PC, Chen YC, Chiang CF, Mo LR, Wei SY, Hsieh WY, Lin WL.

Int J Nanomedicine. 2016 May 12;11:2021-37. doi: 10.2147/IJN.S94139. eCollection 2016.

10.

Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer.

Chang MH, You SL, Chen CJ, Liu CJ, Lai MW, Wu TC, Wu SF, Lee CM, Yang SS, Chu HC, Wang TE, Chen BW, Chuang WL, Soon MS, Lin CY, Chiou ST, Kuo HS, Chen DS; Taiwan Hepatoma Study Group.

Gastroenterology. 2016 Sep;151(3):472-480.e1. doi: 10.1053/j.gastro.2016.05.048. Epub 2016 Jun 4.

PMID:
27269245
11.

Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer.

Wang WL, Wang YC, Chang CY, Lo JL, Kuo YH, Hwang TZ, Wang CC, Mo LR, Lin JT, Lee CT.

Laryngoscope. 2016 May;126(5):1097-102. doi: 10.1002/lary.25728. Epub 2015 Nov 24.

PMID:
27107411
12.

The Spatial Predilection for Early Esophageal Squamous Cell Neoplasia: A "Hot Zone" for Endoscopic Screening and Surveillance.

Wang WL, Chang IW, Chen CC, Chang CY, Lin JT, Mo LR, Wang HP, Lee CT.

Medicine (Baltimore). 2016 Apr;95(15):e3311. doi: 10.1097/MD.0000000000003311.

13.

Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen-Negative Patients.

Hsu YC, Mo LR, Chang CY, Wu MS, Kao JH, Wang WL, Yang TH, Wang CS, Chiang MF, Chen CC, Fang YJ, Hung HW, Wu CY, Lin JT.

Clin Gastroenterol Hepatol. 2016 Oct;14(10):1490-1498.e3. doi: 10.1016/j.cgh.2016.03.024. Epub 2016 Mar 24.

PMID:
27018299
14.

Radiofrequency Ablation Versus Endoscopic Submucosal Dissection in Treating Large Early Esophageal Squamous Cell Neoplasia.

Wang WL, Chang IW, Chen CC, Chang CY, Mo LR, Lin JT, Wang HP, Lee CT.

Medicine (Baltimore). 2015 Dec;94(49):e2240. doi: 10.1097/MD.0000000000002240.

15.

Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients.

Yang CC, Tsai WL, Su WW, Huang CF, Cheng PN, Lo CC, Tseng KC, Mo LR, Wang CH, Hsu SJ, Lai HC, Su CW, Liu CJ, Peng CY, Yu ML.

PLoS One. 2015 Sep 14;10(9):e0137852. doi: 10.1371/journal.pone.0137852. eCollection 2015.

16.

Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.

Wang CH, Wey KC, Mo LR, Chang KK, Lin RC, Kuo JJ.

Asian Pac J Cancer Prev. 2015;16(9):3595-604. Review.

17.

The impact of human papillomavirus infection on the survival and treatment response of patients with esophageal cancers.

Wang WL, Wang YC, Lee CT, Chang CY, Lo JL, Kuo YH, Hsu YC, Mo LR.

J Dig Dis. 2015 May;16(5):256-63. doi: 10.1111/1751-2980.12236.

PMID:
25708698
18.

Circumferential balloon-based radiofrequency ablation for ultralong and extensive flat esophageal squamous neoplasia.

Wang WL, Chang IW, Chang CY, Lin JT, Mo LR, Wang HP, Lee CT.

Gastrointest Endosc. 2014 Dec;80(6):1185-9. doi: 10.1016/j.gie.2014.07.025. Epub 2014 Sep 23. No abstract available.

PMID:
25257127
19.

Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B.

Hsu YC, Wu CY, Lane HY, Chang CY, Tai CM, Tseng CH, Lo GH, Perng DS, Lin JT, Mo LR.

J Antimicrob Chemother. 2014 Jul;69(7):1920-7. doi: 10.1093/jac/dku041. Epub 2014 Feb 26.

PMID:
24576950
20.

Effectiveness of intragastric balloon treatment for obese patients: one-year follow-up after balloon removal.

Tai CM, Lin HY, Yen YC, Huang CK, Hsu WL, Huang YW, Chang CY, Wang HP, Mo LR.

Obes Surg. 2013 Dec;23(12):2068-74. doi: 10.1007/s11695-013-1027-7.

PMID:
23832520

Supplemental Content

Loading ...
Support Center